In pancreatic cancer, HNF4G was also found to be induced by SMAD4 deficiency, promoting progression and metastasis but being suppressed by the metformin/APMK signaling pathway (Wang et al., 2021). Here, SMAD4 is linked to pancreatic neoplasm.